Be Ready to Dispense Remsima SC for Rheumatoid Arthritis
May 2022
Remsima SC is the first SUBCUTANEOUS version of Remicade (infliximab) for rheumatoid arthritis.
It's also a biosimilar. This means it's highly similar to infliximab and has the same safety, purity, and potency.
Remsima SC joins the INTRAVENOUS biosimilars of infliximab...such as Avsola, Inflectra, or Renflexis.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote